Rivelsa Kit
Product Images NDC 0093-6031

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Rivelsa (NDC 0093-6031). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

A bar chart depicting the percentage of bleeding and/or spotting versus bleeding alone across four cycles of days for a product study. Each cycle shows two stacked bars representing ≥7 days and ≥20 days durations, with percentages noted for both bleeding and bleeding plus spotting. The cycles span various day ranges with decreasing overall percentages from Cycle 1 (Days 1-91) to Cycle 4 (Days 274-364). The chart includes a legend identifying the two bleeding categories.*

FDA Label Image

Image 10

Rivelsa kit packaging label displaying the medication containing levonorgestrel and ethinyl estradiol tablets along with ethinyl estradiol tablets, including specific dosages for each component. The label indicates 2 extended-cycle tablet dispensers with 91 tablets each. Labeler is Teva Pharmaceuticals USA, Inc. Additional details include dosage instructions, regulatory information, and barcodes.*

FDA Label Image

Image 2

A forest plot comparing effect estimates from various studies on combined oral contraceptive (COC) use versus never use. The chart lists studies from 2002 to 2017 on the left, with corresponding effect estimates (odds ratios, hazard ratios, or relative risks) shown as points and confidence intervals on the right, plotted against a horizontal axis labeled 'Effect Estimate' ranging from -1.50 to 2.00. The graph is divided into two sections: 'Ever COC vs. Never COC Use' and 'Current COC use vs. Never Use.'*

FDA Label Image

Image 3

Chemical structure of a steroid molecule, which is likely one of the active ingredients in the Rivelsa kit, such as Levonorgestrel or Ethinyl Estradiol. The structure shows multiple fused rings, hydroxyl, methyl groups, and a ketone group, characteristic of synthetic hormones.*

FDA Label Image

Image 4

Chemical structure diagram of Ethinyl Estradiol, an active ingredient in Rivelsa, a levonorgestrel/ethinyl estradiol and ethinyl estradiol combination kit by Teva Pharmaceuticals USA.*

FDA Label Image

Image 5

An illustrated diagram showing a vertical arrow labeled with pregnancy rates per 100 women in one year, from fewer than 1 to 85 or more, representing more to fewer pregnancies. It categorizes birth control methods: implants, injections, intrauterine devices, and sterilization with the fewest pregnancies; birth control pills, skin patch, and vaginal rings with hormones next; condoms and diaphragm in the middle; no sex during fertile days, spermicide, and withdrawal with more pregnancies; and no birth control with the most pregnancies.*

FDA Label Image

Image 6

Rivelsa kit blister pack, containing tablets arranged in a weekly cycle from Sunday to Saturday. The label shows the active ingredients: levonorgestrel and ethinyl estradiol in varying doses per tablet, and provides a note to see lot and expiration date on the reverse. The labeler is Teva Pharmaceuticals USA, Inc., with Product NDC 0093-6031.*

FDA Label Image

Image 7

Rivelsa oral contraceptive kit containing Levonorgestrel/Ethinyl Estradiol and Ethinyl Estradiol tablets. The image shows a 28-day blister pack with tablets arranged by days of the week SUN to SAT across four rows. Each tablet is labeled with its respective active ingredients and dosages. The labeler is Teva Pharmaceuticals USA, Inc., and the NDC is 0093-6031.*

FDA Label Image

Image 8

Rivelsa kit with a partially filled blister pack showing multiple round tablets arranged in rows labeled by days of the week. The package lists dosages for levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets, with some tablets shaded differently to indicate various strengths or types. The label includes the product name Rivelsa and week/day markers for tablet administration.*

FDA Label Image

Image 9

Rivelsa (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets kit by Teva Pharmaceuticals USA, Inc. The kit contains 2 extended-cycle tablet dispensers with 91 tablets each. Strengths include levonorgestrel 0.15 mg, ethinyl estradiol 0.02 mg and 0.025 mg, plus ethinyl estradiol 0.01 mg tablets. The label includes dosing instructions and storage information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.